Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WZTL-002 |
Synonyms | |
Therapy Description |
WZTL-002 is composed of autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19 and containing CD28 and TLR2 co-stimulatory domains, which decrease tumor growth (Blood (2023) 142 (Supplement 1): 890). |